Prognosis of diabetic patients post-MI: the role of ACE inhibitor treatment. GISSI-3 Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Zuanetti
G
G
Dept. of Cardiovascular Research, Instituto di Ricerche Farmacologiche, Mario Negri, Milano, Italy.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000401:mortality*; D005260:Female; D005500:Follow-Up Studies; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors